Information  X 
Enter a valid email address

China New Energy Ltd (CNEL)

  Print      Mail a friend

Monday 25 July, 2011

China New Energy Ltd

Result of AGM

RNS Number : 9721K
China New Energy Ltd
25 July 2011

25 July 2011


China New Energy Limited

("CNE" or "the Company")


Results of AGM


The Board of CNE (AIM:CNEL), the AIM quoted engineering and technology solutions provider to the bioenergy sector, announces that at the AGM held earlier today, all resolutions were duly passed.


For further information please visit or contact:


China New Energy Limited


Richard Bennett


+ 44 (0)20 7148 3148 or

Cairn Financial Advisers LLP (Nominated Adviser)

Tel: 020 7148 7900

Jo Turner / Liam Murray               



SVS Securities plc (Broker)

Tel: 020 7638 5600

Alex Mattey / Ian Callaway



Walbrook PR Ltd (Financial Public Relations)

Tel: 020 7933 8780

Paul Cornelius

Mob: 07866 384 707 or

Jack Rich

Mob: 07584 391 303 or



About CNE

CNE is a technology, process and engineering solutions provider for bioethanol and biobutanol projects focusing predominantly on the construction of ethanol production plants. Through its wholly owned subsidiary, Guangdong Zhongke Tianyuan New Energy Science and Technology Co. Ltd ("ZKTY"), the Group provides process technology, engineering designs, plant manufacturing and operational services in connection with the production of fuel ethanol, edible ethanol, biobutanol, bioacetic acid and other chemicals from agricultural plant materials and waste.


ZKTY provides its services to primary producers and users of bioenergy and the Group's activities are principally based in China. However, it also provides services to overseas customers in areas including Romania, Taiwan, Russia, Thailand and Indonesia.


ZKTY has an established track record having advised on 88 projects globally with an aggregate production capacity of approximately 9.0 million tonnes per year and a total contract value of approximately RMB1.5 billion. ZKTY has proprietary and patented bioenergy technology, and maintains its own research and development laboratory to further develop its technology and patent portfolio.


CNE listed on AIM in May 2011, raising £655,201 at 7p per share. The market capitalisation of the Company at the Placing Price on Admission was £20.8m.



This information is provided by RNS
The company news service from the London Stock Exchange